Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.810
-0.060 (-2.09%)
At close: Jun 27, 2025, 4:00 PM
2.820
+0.010 (0.36%)
After-hours: Jun 27, 2025, 7:43 PM EDT
Sana Biotechnology Employees
Sana Biotechnology had 194 employees as of December 31, 2024. The number of employees decreased by 134 or -40.85% compared to the previous year.
Employees
194
Change (1Y)
-134
Growth (1Y)
-40.85%
Revenue / Employee
n/a
Profits / Employee
-$1,075,634
Market Cap
633.81M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 194 | -134 | -40.85% |
Dec 31, 2023 | 328 | -93 | -22.09% |
Dec 31, 2022 | 421 | 35 | 9.07% |
Dec 31, 2021 | 386 | 121 | 45.66% |
Dec 31, 2020 | 265 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SANA News
- 5 days ago - Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - GlobeNewsWire
- 5 days ago - Two Biotech Stocks Poised For Big Moves On Monday - Benzinga
- 19 days ago - Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions - GlobeNewsWire
- 4 weeks ago - Sana Biotechnology to Present at June 2025 Investor Conferences - GlobeNewsWire
- 5 weeks ago - Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment - Seeking Alpha
- 5 weeks ago - The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants - Benzinga
- 6 weeks ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference - GlobeNewsWire